New Target Biology

About Biovista

Biovista is a private, AI-driven healthcare analytics company with a decade-long track record in drug repositioning and clinical de-risking. Its flagship platform, Vizit, leverages machine learning and natural language processing across multiple biomedical corpora to generate novel therapeutic hypotheses and optimize drug development. The company generates revenue by offering its AI platform and analytical services to pharmaceutical, generics, and life sciences companies, positioning itself as a partner for cost-effective therapy development and pipeline management. Its focus on human-in-the-loop AI and real-world application differentiates it from purely computational players.

Therapeutic Areas

Other Various Diseases Drugs